C517943 | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone | "[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A3 mRNA" | 22645130 |
C517943 | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone | "[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A3 protein" | 22645130 |
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of SLC1A3 mRNA | 19933214 |
C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC1A3 protein" | 21673325 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SLC1A3 mRNA" | 23146750 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SLC1A3 mRNA" | 23146750 |
C553295 | 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile | "2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile results in decreased activity of SLC1A3 protein" | 22645130 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SLC1A3 mRNA" | 23196670 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased activity of GPER1 protein] inhibits the reaction [[Raloxifene Hydrochloride results in increased activity of GPER1 protein] which results in increased expression of SLC1A3 protein]" | 24782323 |
C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased activity of GPER1 protein] which results in decreased expression of SLC1A3 protein" | 24782323 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of SLC1A3 mRNA | 29067470 |
D000082 | Acetaminophen | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
D020106 | Acrylamide | Acrylamide results in increased expression of SLC1A3 mRNA | 12853321 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of SLC1A3 mRNA | 22100608 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of SLC1A3 mRNA | 28522335 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of SLC1A3 mRNA | 21298039 |
D000602 | Amino Acids, Peptides, and Proteins | "SLC1A3 affects the uptake of Amino Acids, Peptides, and Proteins" | 15608650 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of SLC1A3 mRNA | 16483693 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased oxidation of SLC1A3 mRNA | 18506841 |
D000726 | Androgen Antagonists | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of SLC1A3 mRNA" | 19446018 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [APP protein results in decreased expression of SLC1A3 protein] | 20816828 |
C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of SLC1A3 mRNA | 22316170 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of SLC1A3 mRNA | 22300585 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA | 20660070 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA | 22154832 |
D004958 | Estradiol | Estradiol results in increased expression of SLC1A3 mRNA | 22154832 |
D004958 | Estradiol | Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 19453300 |
D004958 | Estradiol | Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 19453300 |
D004958 | Estradiol | Estradiol results in increased expression of SLC1A3 mRNA | 19453300 |
D004958 | Estradiol | Estradiol results in increased expression of SLC1A3 protein | 19453300 |
C095105 | bexarotene | bexarotene results in decreased expression of SLC1A3 mRNA | 16648578 |
C006780 | bisphenol A | bisphenol A affects the expression of SLC1A3 mRNA | 20170705 |
C006780 | bisphenol A | bisphenol A affects the expression of SLC1A3 mRNA | 25181051 |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA | 25607892 |
C013418 | bromfenacoum | bromfenacoum results in increased expression of SLC1A3 protein | 28903499 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA | 25607892 |
D020148 | Butyric Acid | Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 28610743 |
D020148 | Butyric Acid | Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 28610743 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of SLC1A3 protein | 17544377 |
D005023 | Ethylene Chlorohydrin | Ethylene Chlorohydrin results in decreased expression of SLC1A3 mRNA | 27596522 |
D005023 | Ethylene Chlorohydrin | Ethylene Chlorohydrin results in decreased expression of SLC1A3 protein | 27596522 |
D002737 | Chloroprene | Chloroprene results in decreased expression of SLC1A3 mRNA | 23125180 |
D004390 | Chlorpyrifos | [Chlorpyrifos co-treated with NGF protein] results in increased expression of SLC1A3 mRNA | 20600679 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of SLC1A3 mRNA | 20600679 |
D002784 | Cholesterol | Cholesterol results in increased expression of SLC1A3 mRNA | 26296894 |
C418118 | CI 1044 | CI 1044 results in increased expression of SLC1A3 mRNA | 17569694 |
D060729 | Coal Ash | Coal Ash results in decreased expression of SLC1A3 mRNA | 19000753 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of SLC1A3 mRNA | 22941251 |
D003300 | Copper | [NSC 689534 binds to Copper] which results in decreased expression of SLC1A3 mRNA | 20971185 |
D003300 | Copper | Copper deficiency results in increased expression of SLC1A3 mRNA | 26033743 |
D003474 | Curcumin | Curcumin inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] | 23267840 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of SLC1A3 mRNA | 25047013 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of SLC1A3 mRNA | 22733784 |
D003975 | Diazepam | Diazepam results in increased oxidation of SLC1A3 mRNA | 18506841 |
D003976 | Diazinon | Diazinon results in decreased expression of SLC1A3 mRNA | 17452286 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of SLC1A3 mRNA | 21266533 |
D002945 | Cisplatin | SLC1A3 mRNA affects the susceptibility to Cisplatin | 18610736 |
C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of SLC1A3 mRNA | 26924002 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of SLC1A3 mRNA | 18042831 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of SLC1A3 mRNA | 19030233 |
D002117 | Calcitriol | Calcitriol results in increased expression of SLC1A3 mRNA | 27107558 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC1A3 mRNA" | 19480007 |
C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of SLC1A3 mRNA | 26924002 |
C061132 | diphenyldiselenide | diphenyldiselenide results in increased expression of SLC1A3 protein | 19926633 |
D004785 | Environmental Pollutants | Environmental Pollutants results in increased expression of SLC1A3 mRNA | 19118595 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA | 25607892 |
D000431 | Ethanol | Ethanol affects the expression of SLC1A3 mRNA | 11772933 |
D000431 | Ethanol | Ethanol results in increased expression of SLC1A3 mRNA | 20655511 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of SLC1A3 mRNA | 20170705|2686566 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of SLC1A3 mRNA | 15834898|1755790 |
D018683 | Excitatory Amino Acid Agents | Mercuric Chloride inhibits the reaction [SLC1A3 protein results in increased uptake of Excitatory Amino Acid Agents] | 16632895 |
D018683 | Excitatory Amino Acid Agents | SLC1A3 protein results in increased uptake of Excitatory Amino Acid Agents | 16632895 |
C039281 | furan | furan results in increased expression of SLC1A3 mRNA | 27387713 |
D019833 | Genistein | Genistein results in decreased expression of SLC1A3 mRNA | 26865667 |
D005947 | Glucose | Glucose results in decreased expression of SLC1A3 mRNA | 26677078 |
D005947 | Glucose | Glucose results in decreased expression of SLC1A3 protein | 26677078 |
D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA] | 26677078 |
D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] | 26677078 |
D006220 | Haloperidol | Haloperidol results in decreased expression of SLC1A3 mRNA | 15860345 |
D017313 | Fenretinide | Fenretinide results in decreased expression of SLC1A3 mRNA | 28973697 |
D017313 | Fenretinide | Fenretinide results in increased expression of SLC1A3 mRNA | 28973697 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of SLC1A3 mRNA | 20044591 |
D002112 | Calcifediol | Calcifediol deficiency results in decreased expression of SLC1A3 mRNA | 17293106 |
D007612 | Kanamycin | SLC1A3 affects the susceptibility to Kanamycin | 15862894 |
D007854 | Lead | Lead results in increased expression of SLC1A3 mRNA | 15955607 |
D007854 | Lead | Lead results in increased expression of SLC1A3 protein | 15955607 |
C008261 | lead acetate | lead acetate affects the expression of SLC1A3 mRNA | 15985313 |
C008261 | lead acetate | lead acetate results in increased expression of SLC1A3 mRNA | 11578147 |
D008345 | Manganese | Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 28610743 |
D008345 | Manganese | Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 28610743 |
D008345 | Manganese | Manganese results in decreased expression of SLC1A3 mRNA | 28610743 |
D008345 | Manganese | Manganese results in decreased expression of SLC1A3 protein | 28610743 |
D008345 | Manganese | Valproic Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 28610743 |
D008345 | Manganese | Valproic Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 28610743 |
D008345 | Manganese | Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 19453300 |
D008345 | Manganese | Estradiol inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 19453300 |
D008345 | Manganese | Manganese results in decreased expression of SLC1A3 mRNA | 19453300 |
D008345 | Manganese | Manganese results in decreased expression of SLC1A3 protein | 19453300 |
D008345 | Manganese | Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 19453300 |
D008345 | Manganese | Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 19453300 |
C025340 | manganese chloride | manganese chloride results in decreased expression of SLC1A3 mRNA | 12387356|1961535 |
C025340 | manganese chloride | manganese chloride results in decreased expression of SLC1A3 protein | 19615351|2478232 |
C025340 | manganese chloride | Raloxifene Hydrochloride inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] | 24782323 |
C025340 | manganese chloride | Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA] | 19615351 |
C025340 | manganese chloride | Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] | 19615351 |
C039798 | manganese sulfate | manganese sulfate results in decreased expression of SLC1A3 protein | 17347134 |
C039798 | manganese sulfate | manganese sulfate results in increased expression of SLC1A3 mRNA | 17347134 |
C039798 | manganese sulfate | manganese sulfate results in decreased expression of SLC1A3 mRNA | 12387356 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in increased expression of SLC1A3 mRNA | 20843944 |
D008627 | Mercuric Chloride | Mercuric Chloride inhibits the reaction [SLC1A3 protein results in increased uptake of Excitatory Amino Acid Agents] | 16632895 |
D008627 | Mercuric Chloride | Mercuric Chloride results in decreased expression of SLC1A3 mRNA | 16632895 |
D008694 | Methamphetamine | Methamphetamine results in increased expression of SLC1A3 mRNA | 18419818 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of and results in decreased activity of SLC1A3 protein | 22966415 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of SLC1A3 mRNA | 22966415 |
C004925 | methylmercuric chloride | Riluzole inhibits the reaction [methylmercuric chloride results in decreased expression of and results in decreased activity of SLC1A3 protein] | 22966415 |
C004925 | methylmercuric chloride | Riluzole inhibits the reaction [methylmercuric chloride results in decreased expression of SLC1A3 mRNA] | 22966415 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased activity of SLC1A3 protein | 16286679 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC1A3 mRNA" | 20188158 |
C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of SLC1A3 mRNA | 26924002 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of SLC1A3 mRNA | 15674844 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of SLC1A3 mRNA" | 25554681 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of SLC1A3 mRNA | 12832660 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in decreased expression of SLC1A3 mRNA | 17616710 |
C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in decreased expression of SLC1A3 mRNA | 20971185 |
C025589 | ochratoxin A | ochratoxin A affects the expression of SLC1A3 protein | 20558201 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA | 25607892 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA | 25607892 |
D016627 | Oxidopamine | Oxidopamine results in increased expression of SLC1A3 mRNA | 15518916 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of SLC1A3 mRNA | 25729387 |
C030110 | oxaliplatin | oxaliplatin results in increased expression of SLC1A3 mRNA | 25729387 |
D010100 | Oxygen | [SCH 442416 co-treated with Oxygen deficiency] results in increased expression of SLC1A3 mRNA | 22969972 |
D010126 | Ozone | Ozone results in decreased expression of SLC1A3 mRNA | 17095637 |
D017239 | Paclitaxel | Paclitaxel results in decreased expression of SLC1A3 protein | 16361064 |
D000073878 | Palm Oil | Palm Oil results in decreased expression of SLC1A3 mRNA | 18042831 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C496932 | panobinostat | panobinostat results in increased expression of SLC1A3 mRNA | 26272509 |
D010261 | Paraoxon | Paraoxon results in increased expression of SLC1A3 mRNA | 27769869 |
D010261 | Paraoxon | Paraoxon results in increased expression of SLC1A3 protein | 27769869 |
D052638 | Particulate Matter | [SLC1A3 gene mutant form affects the susceptibility to Particulate Matter] which results in increased expression of SLC1A3 mRNA | 21222557|2122255 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of SLC1A3 mRNA | 19429403 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of SLC1A3 mRNA | 18692542|2782593 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of SLC1A3 mRNA | 19429403 |
D010578 | Petroleum | Petroleum affects the expression of SLC1A3 mRNA | 25208076 |
D010656 | Phenylephrine | Phenylephrine results in increased expression of SLC1A3 mRNA | 18158353 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of SLC1A3 mRNA | 12832660 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of SLC1A3 mRNA | 19162173 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA | 20660070 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in increased expression of SLC1A3 mRNA | 22154832 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA] | 24782323 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 protein] | 24782323 |
D020849 | Raloxifene Hydrochloride | "[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased activity of GPER1 protein] inhibits the reaction [[Raloxifene Hydrochloride results in increased activity of GPER1 protein] which results in increased expression of SLC1A3 protein]" | 24782323 |
D020849 | Raloxifene Hydrochloride | ESR1 protein promotes the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA] | 24782323 |
D020849 | Raloxifene Hydrochloride | ESR2 protein promotes the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA] | 24782323 |
D020849 | Raloxifene Hydrochloride | pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA] | 24782323 |
D020849 | Raloxifene Hydrochloride | pyrrolidine dithiocarbamic acid inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A3 protein] | 24782323 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] | 24782323 |
D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride results in increased activity of GPER1 protein] which results in increased expression of SLC1A3 protein | 24782323 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in increased expression of SLC1A3 mRNA | 24782323 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in increased expression of SLC1A3 protein | 24782323 |
C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 mRNA] | 26677078 |
C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in decreased expression of SLC1A3 protein] | 26677078 |
C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] | 26677078 |
C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 protein] | 26677078 |
D019782 | Riluzole | Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 mRNA] | 19615351 |
D019782 | Riluzole | Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A3 protein] | 19615351 |
D019782 | Riluzole | Riluzole inhibits the reaction [methylmercuric chloride results in decreased expression of and results in decreased activity of SLC1A3 protein] | 22966415 |
D019782 | Riluzole | Riluzole inhibits the reaction [methylmercuric chloride results in decreased expression of SLC1A3 mRNA] | 22966415 |
D019782 | Riluzole | Riluzole results in increased expression of SLC1A3 mRNA | 22966415 |
D019782 | Riluzole | Riluzole results in increased expression of SLC1A3 protein | 22966415 |
D012524 | Sarin | Sarin results in increased expression of SLC1A3 protein | 25842371 |
C416650 | SCH 442416 | [SCH 442416 co-treated with Oxygen deficiency] results in increased expression of SLC1A3 mRNA | 22969972 |
C017947 | sodium arsenite | sodium arsenite results in decreased activity of SLC1A3 promoter | 21602192 |
C017947 | sodium arsenite | sodium arsenite results in decreased activity of SLC1A3 protein | 21602192 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of SLC1A3 mRNA | 21602192 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of SLC1A3 mRNA | 22714537 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of and results in decreased activity of SLC1A3 protein | 22020379 |
D013311 | Streptozocin | Curcumin inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] | 23267840 |
D013311 | Streptozocin | INS1 protein inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] | 23267840 |
D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 mRNA] | 26677078 |
D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in decreased expression of SLC1A3 protein] | 26677078 |
D013311 | Streptozocin | Streptozocin results in decreased expression of SLC1A3 mRNA | 23267840|2667707 |
D013311 | Streptozocin | Streptozocin results in decreased expression of SLC1A3 protein | 26677078 |
D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 19453300 |
D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 19453300 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of SLC1A3 mRNA | 19453300 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of SLC1A3 protein | 19453300 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA | 21570461|2637764 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of SLC1A3 mRNA | 19933214 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SLC1A3 mRNA | 22298810 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of SLC1A3 mRNA | 23557971 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of SLC1A3 mRNA | 28065790 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of SLC1A3 mRNA | 25729387 |
D014212 | Tretinoin | Tretinoin results in increased expression of SLC1A3 mRNA | 21934132 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C012589 | trichostatin A | trichostatin A results in increased expression of SLC1A3 mRNA | 24935251|2627250 |
C012589 | trichostatin A | trichostatin A results in decreased expression of SLC1A3 mRNA | 15901671 |
C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of SLC1A3 mRNA | 19042947 |
D014415 | Tunicamycin | Tunicamycin results in increased expression of SLC1A3 mRNA | 17127020 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of SLC1A3 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of SLC1A3 mRNA | 23179753|2438349 |
D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 mRNA] | 28610743 |
D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Manganese results in decreased expression of SLC1A3 protein] | 28610743 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of SLC1A3 mRNA | 23665938 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of SLC1A3 mRNA | 15901671 |
D001335 | Vehicle Emissions | [SLC1A3 gene mutant form affects the susceptibility to Vehicle Emissions] which results in increased expression of SLC1A3 mRNA | 21222557|2122255 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of SLC1A3 gene | 25560391 |
C025643 | vinclozolin | vinclozolin results in increased expression of SLC1A3 mRNA | 22570695 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A3 mRNA" | 27188386 |
C111237 | vorinostat | vorinostat results in increased expression of SLC1A3 mRNA | 26272509 |
D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical affects the expression of SLC1A3 mRNA" | 25208076 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of SLC1A3 mRNA | 24714768 |